CCR5Δ32 mutations do not determine COVID-19 disease course

OBJECTIVES: To determine the impact of the 32 bp deletion (CCR5Δ32) in the coding region of the C-C chemokine receptor 5 (CCR5) on the risk of contracting SARS-CoV-2 and severe COVID-19. METHODS: Cross-sectional study among stem cell donors registered with DKMS in Germany. Genetic information was li...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernas, Stefanie N., Baldauf, Henning, Wendler, Sarah, Heidenreich, Falk, Lange, Vinzenz, Hofmann, Jan A., Sauter, Jürgen, Schmidt, Alexander H., Schetelig, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923852/
https://www.ncbi.nlm.nih.gov/pubmed/33667698
http://dx.doi.org/10.1016/j.ijid.2021.02.108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923852/
https://www.ncbi.nlm.nih.gov/pubmed/33667698
http://dx.doi.org/10.1016/j.ijid.2021.02.108

Ejemplares similares